ストックスクリーナーアプリを入手
12.34
3.09%
0.37
アフターアワーズ：
12.34
前日終値:
$11.97
開ける：
$11.97
24時間の取引高:
777.65K
Relative Volume:
0.76
時価総額：
$729.00M
収益：
-
当期純損益:
$-153.16M
株価収益率:
-3.3442
EPS:
-3.69
ネットキャッシュフロー:
$-134.48M
1週間 パフォーマンス:
+13.52%
1か月 パフォーマンス:
+19.00%
6か月 パフォーマンス:
+50.86%
1年 パフォーマンス:
+19.81%
1日の値動き範囲:
$11.53
$12.64
1週間の範囲:
$10.78
$12.99
52週間の値動き範囲:
$5.68
$13.33
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
CGEM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
12.34 | 707.14M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-21 | 再開されました | H.C. Wainwright | Buy |
| 2025-06-11 | 再開されました | Stifel | Buy |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-05-01 | 開始されました | Stifel | Buy |
| 2024-04-15 | 開始されました | William Blair | Outperform |
| 2024-02-15 | 開始されました | Wedbush | Outperform |
| 2023-06-15 | 開始されました | TD Cowen | Outperform |
| 2022-11-21 | 開始されました | BTIG Research | Buy |
| 2021-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-02-02 | 開始されました | Evercore ISI | Outperform |
| 2021-02-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-02-02 | 開始されました | SVB Leerink | Outperform |
| 2021-02-01 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cullinan Therapeutics Inc (CGEM) 最新ニュース
Cullinan Therapeutics, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $49,200.00 in Stock - Defense World
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Is Cullinan Therapeutics (NASDAQ:CGEM) In A Good Position To Invest In Growth? - Sahm
Cullinan Therapeutics (NASDAQ:CGEM) Cut to "Sell" at Wall Street Zen - MarketBeat
Stocks to watch: Cullinan Therapeutics sees RS rating jump to 91 - MSN
Insider Sell: Jennifer Michaelson Sells 4,000 Shares of Cullinan Therapeutics Inc (CGEM) - GuruFocus
Jennifer Michaelson Sells 4,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat
Gainers Report: Can Cullinan Therapeutics Inc outperform under higher oil prices2025 Support & Resistance & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Here's What Could Help Cullinan Therapeutics (CGEM) Maintain Its Recent Price Strength - Yahoo Finance
JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36 - 富途牛牛
Cullinan Therapeutics (NASDAQ:CGEM) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Stocks To Watch: Cullinan Therapeutics Sees RS Rating Jump To 91 - Investor's Business Daily
Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 10.6%Here's Why - MarketBeat
History Review: What is the Moat Score of Cullinan Therapeutics IncIPO Watch & Verified Momentum Stock Alerts - baoquankhu1.vn
Will Cullinan Therapeutics Inc benefit from AI trends2025 Market WrapUp & Risk Controlled Swing Alerts - baoquankhu1.vn
Cullinan Therapeutics Stock Slides After-Hours Despite $692M Autoimmune Drug Pact With Genrix - MSN
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 6.2%Here's What Happened - MarketBeat
Published on: 2026-01-11 22:17:06 - ulpravda.ru
Cullinan Therapeutics (CGEM) price target increased by 19.75% to 32.84 - MSN
Cullinan Therapeutics provides corporate update, anticipated 2026 milestones - Yahoo Finance
Market Fear: Will Cullinan Therapeutics Inc. stock split again soonWeekly Stock Report & Real-Time Volume Triggers - ulpravda.ru
Will Cullinan Therapeutics Inc. stock split again soonProfit Target & Weekly Return Optimization Alerts - ulpravda.ru
How strong is Cullinan Therapeutics Inc. stock balance sheetQuarterly Trade Review & Reliable Breakout Stock Forecasts - ulpravda.ru
Today's Analyst Ratings Update: CGEM Price Target Raised to $27 - GuruFocus
Cullinan Management Outlines Catalyst-Rich 2026 Pipeline Outlook - TipRanks
Cullinan Therapeutics (CGEM) Outlines Key Developments for 2026 - GuruFocus
Cullinan Therapeutics plans data readouts for key autoimmune programs By Investing.com - Investing.com Australia
Cullinan Therapeutics plans data readouts for key autoimmune programs - Investing.com India
Cullinan Therapeutics Outlines 2026 Milestones for CLN-978 and CLN-049 Programs, NDA Submission for Zipalertinib - Quiver Quantitative
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones - Chartmill
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 9.5%Here's Why - MarketBeat
Cullinan Therapeutics, Inc.Common Stock (NQ:CGEM) - FinancialContent
Oncology Drugs Fast-Tracked by the FDA in December 2025 - Oncology News Central
Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 3.9%What's Next? - MarketBeat
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Nadim Ahmed Sells 9,922 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat
Assenagon Asset Management S.A. Has $1.05 Million Stake in Cullinan Therapeutics, Inc. $CGEM - MarketBeat
Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap DownTime to Sell? - MarketBeat
Insider Sell: Jennifer Michaelson Sells Shares of Cullinan Thera - GuruFocus
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $13,463.45 in Stock - MarketBeat
Cullinan Therapeutics CSO Sells Shares - TradingView — Track All Markets
Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $28,023.66 in Stock - Defense World
Cullinan Therapeutics (CGEM) Price Target Increased by 19.75% to 32.84 - Nasdaq
Will Cullinan Therapeutics Inc. stock deliver shareholder value2025 Price Targets & Weekly High Potential Stock Alerts - ulpravda.ru
Cullinan Therapeutics price target raised to $34 from $25 at Wedbush - MSN
Cullinan Therapeutics Earnings Notes - Trefis
Cullinan Therapeutics shows rising price performance with jump to 93 RS rating - MSN
Is Cullinan Therapeutics Inc. stock a contrarian buy2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - Улправда
Cullinan Therapeutics Inc (CGEM) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):